{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:51:40Z","timestamp":1792608700978,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.radonc.2023.109981","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T23:51:03Z","timestamp":1698969063000},"page":"109981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model"],"prefix":"10.1016","volume":"190","author":[{"given":"Jun Yeong","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Guk","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoomin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyuck","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109981_b0005","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2023.109981_b0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamaoncol.2018.4224","article-title":"Long-term clinical outcomes and biomarker analyses of atezolizumab therapy for patients with metastatic triple-negative breast cancer: a phase 1 study","volume":"5","author":"Emens","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109981_b0015","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","article-title":"Pembrolizumab in patients with advanced triple-negative breast cancer: Phase Ib keynote-012 study","volume":"34","author":"Nanda","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109981_b0020","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2023.109981_b0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.semradonc.2021.02.001","article-title":"Mechanisms of Immune Modulation by Radiation","volume":"31","author":"Spina","year":"2021","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109981_b0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2016.07.013","article-title":"Immune modulation by hypofractionated stereotactic radiation therapy: therapeutic implications","volume":"120","author":"Popp","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109981_b0035","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-019-0432-4","article-title":"Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial","volume":"25","author":"Voorwerk","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2023.109981_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41523-022-00404-2","article-title":"Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +\/\u2212 trastuzumab in patients with breast cancer brain metastases","volume":"8","author":"Page","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.radonc.2023.109981_b0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.clbc.2020.01.012","article-title":"A Phase II study of pembrolizumab in combination with palliative radiotherapy for hormone receptor-positive metastatic breast cancer","volume":"20","author":"Barroso-Sousa","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.radonc.2023.109981_b0050","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/cncr.32599","article-title":"A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancer","volume":"126","author":"Ho","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109981_b0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.coi.2011.12.011","article-title":"Modulation of GITR for cancer immunotherapy","volume":"24","author":"Schaer","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.radonc.2023.109981_b0060","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/2326-6066.CIR-13-0086","article-title":"GITR pathway activation abrogates tumor immune suppression through loss of regulatory T-cell lineage stability","volume":"1","author":"Schaer","year":"2013","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.radonc.2023.109981_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010436","article-title":"Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation","volume":"5","author":"Cohen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2023.109981_b0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22885-8","article-title":"Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas","volume":"12","author":"Amoozgar","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2023.109981_b0075","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00262-010-0866-5","article-title":"Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy","volume":"59","author":"Coe","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.radonc.2023.109981_b0080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20130573","article-title":"Activating Fc \u03b3 receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies","volume":"210","author":"Bulliard","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.radonc.2023.109981_b0085","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd9882","article-title":"Triple-modality therapy maximizes antitumor immune responses in a mouse model of mesothelioma","volume":"13","author":"Murakami","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.radonc.2023.109981_b0090","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1158\/0008-5472.CAN-16-0797","article-title":"Dual roles for regulatory T-cell depletion and costimulatory signaling in agonistic GITR targeting for tumor immunotherapy","volume":"77","author":"Mahne","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2023.109981_b0095","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.4049\/jimmunol.179.11.7365","article-title":"Pivotal roles of CD4 + effector T cells in mediating agonistic anti-GITR mAb-induced-immune activation and tumor immunity in CT26 tumors","volume":"179","author":"Zhou","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.radonc.2023.109981_b0100","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.4049\/jimmunol.173.8.5008","article-title":"Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4 + CD25 + T cells","volume":"173","author":"Stephens","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.radonc.2023.109981_b0105","article-title":"Anti-glucocorticoid-induced tumor necrosis factor-related protein (GITR) Therapy overcomes radiation-induced treg immunosuppression and drives abscopal effects","volume":"vol. 9, no. SEP","author":"Schoenhals","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.radonc.2023.109981_b0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2023.109981_b0115","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2021.01.025","article-title":"PI3K\u03b1\u03b4 inhibitor combined with radiation enhances the antitumor immune effect of anti-PD1 in a syngeneic murine triple-negative breast cancer model","volume":"110","author":"Chang","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109981_b0120","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejca.2021.08.029","article-title":"PI3K\u03b3\u03b4 inhibitor plus radiation enhances the antitumour immune effect of PD-1 blockade in syngenic murine breast cancer and humanised patient-derived xenograft model","volume":"157","author":"Han","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109981_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112692","article-title":"Combination of OX40 co-stimulation, radiotherapy, and PD-1 inhibition in a syngeneic murine triple-negative breast cancer model","author":"Han","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.109981_b0130","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200920","article-title":"Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment","volume":"218","author":"Pauken","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.radonc.2023.109981_b0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semradonc.2019.12.009","article-title":"Type I interferon response in radiation-induced anti-tumor immunity","volume":"30","author":"Zhang","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109981_b0140","doi-asserted-by":"crossref","first-page":"15618","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2023.109981_b0145","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2023.109981_b0150","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2023.109981_b0155","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"PNAS"},{"key":"10.1016\/j.radonc.2023.109981_b0160","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","article-title":"The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.radonc.2023.109981_b0165","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182232","article-title":"PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance","volume":"218","author":"Tan","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.radonc.2023.109981_b0170","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","article-title":"Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance","volume":"39","author":"Zitvogel","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.radonc.2023.109981_b0175","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1084\/jem.20052494","article-title":"Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy","volume":"203","author":"Reits","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.radonc.2023.109981_b0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijrobp.2020.04.023","article-title":"The promise of combining radiation therapy with immunotherapy","volume":"108","author":"Jagodinsky","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109981_b0185","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1158\/2326-6066.CIR-17-0040","article-title":"Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment","volume":"5","author":"Muroyama","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.radonc.2023.109981_b0190","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijrobp.2021.05.014","article-title":"Regulatory T cells shape the differential impact of radiation dose-fractionation schedules on host innate and adaptive antitumor immune defenses","volume":"111","author":"Sia","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109981_b0195","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ijrobp.2021.03.003","article-title":"The dynamic alternation of local and systemic tumor immune microenvironment during concurrent chemoradiotherapy of cervical cancer: a prospective clinical trial","volume":"110","author":"Li","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109981_b0200","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1158\/1078-0432.CCR-20-0452","article-title":"Safety and clinical activity of MEDI1873, a novel GITR agonist, in advanced solid tumors","volume":"26","author":"Balmanoukian","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2023.109981_b0205","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaoncol.2019.3848","volume":"6","author":"Heinhuis","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109981_b0210","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","article-title":"Insights gained from single-cell analysis of immune cells in the tumor microenvironment","volume":"39","author":"Ren","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.radonc.2023.109981_b0215","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.cell.2020.05.017","article-title":"Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer","volume":"181","author":"Oh","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.radonc.2023.109981_b0220","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","article-title":"Clonal replacement of tumor-specific T cells following PD-1 blockade","volume":"25","author":"Yost","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2023.109981_b0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ccell.2019.08.009","article-title":"Recruit or reboot? How does anti-PD-1 therapy change tumor-infiltrating lymphocytes?","volume":"36","author":"Callahan","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.radonc.2023.109981_b0230","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/eji.201040943","article-title":"CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity","volume":"41","author":"Bianchini","year":"2011","journal-title":"Eur J Immunol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023898759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T09:11:18Z","timestamp":1734253878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023898759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":46,"alternative-id":["S0167814023898759"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109981","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of local radiotherapy and anti-glucocorticoid-induced tumor necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated anti-tumor effects in murine breast cancer model","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109981"}}